Teza Capital Management’s Idexx Laboratories IDXX Stock Holding History

Teza Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-441	Closed	-$238K	–	659
2024 Q1	$238K	Sell	441 -618	-58%	-$338K	0.03%	480
2023 Q4	$588K	Buy	+1,059	New	+$497K	0.1%	264
2023 Q2	–	Sell	-611	Closed	-$306K	–	644
2023 Q1	$306K	Buy	+611	New	+$292K	0.07%	377
2022 Q2	–	Sell	-595	Closed	-$326K	–	475
2022 Q1	$326K	Buy	+595	New	+$313K	0.12%	260
2021 Q3	–	Sell	-369	Closed	-$233K	–	456
2021 Q2	$233K	Buy	+369	New	+$204K	0.04%	493
2020 Q3	–	Sell	-5,472	Closed	-$1.81M	–	487
2020 Q2	$1.81M	Buy	+5,472	New	+$1.58M	0.4%	56
2018 Q4	–	Sell	-4,393	Closed	-$1.1M	–	401
2018 Q3	$1.1M	Buy	+4,393	New	+$1.07M	0.25%	155
2018 Q2	–	Sell	-3,383	Closed	-$647K	–	512
2018 Q1	$647K	Buy	+3,383	New	+$624K	0.16%	243
2017 Q2	–	Sell	-2,013	Closed	-$311K	–	191
2017 Q1	$311K	Buy	+2,013	New	+$277K	0.09%	343

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Teza Capital Management's IDXX Position: Q2 2024 in Review

Teza Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 441 shares — an estimated $238K sold.

Teza Capital Management first reported a position in IDXX in Q1 2017 and held it in 9 quarters. The position peaked at $1.81M in Q2 2020. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

Teza Capital Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
Teza Capital Management sold 441 Idexx Laboratories shares in Q2 2024, an estimated $238K.
Teza Capital Management first reported a position in Idexx Laboratories in Q1 2017 and held it in 9 quarters.
Teza Capital Management's Idexx Laboratories position peaked at $1.81M in Q2 2020.
1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Teza Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.